Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Pet games online, pet games play free.
Popular Articles
Cellulite Treatment

Abortion-Rights Opponents Using 'Crass Tactics' To Protest Obama's Notre Dame Speech, Opinion Piece Says
Antiabortion-rights "protesters intend to turn Notre Dame"s commencement into a circus" because of their opposition to the university"s invitation to President Obama to receive an honorary degree and deliver a speech at the ceremony on Sunday, Philadelphia Inquirer columnist Monica Yant Kinney writes in an opinion piece. "Never mind that a majority of Catholics voted for Obama in 2008, approve of his job performance and support the university"s invitation," she says. Yant Kinney, a Notre Dame alumna, notes that the university has been inviting presidents to its campus since former President Eisenhower was in office. "Most recently, the class of 2001 honored George W. Bush, who as governor of Texas presided over scores of executions," she writes, adding, "The Catholic Church vehemently opposes the death penalty, yet no bishops boycotted Bush"s visit."Yant Kinney continues that antiabortion-rights advocates Randall Terry, Alan Keyes and others "have already been arrested in the last two weeks," and "[s]ome demonstrators pushed strollers with baby dolls dripping in fake blood." She asks, "And what to make of the soul who hired an airplane to pull a banner of an aborted fetus right by the statue of the Virgin Mary? Where"s the reverence for life in that gesture?" Yant Kinney concludes, "The anti-Obama protesters may be trying to change his mind, but as for hope? With such crass tactics, they"re mostly hoping for attention. I guess they succeeded" (Yant Kinney, Philadelphia Inquirer, 5/13).
generic viagra online
Study Finds Association Between Sudden Death And Stimulant Medications Among Children And Adolescents
Researchers found support for an association between the use of stimulants and sudden unexplained death among children and adolescents, according to a study released today by The American Journal of Psychiatry.
News of the day
Study Reports Early Diagnosis Of Mental Disorders From New Computer Test
A group of doctors in Pittsburgh have developed the Computer Assessment of Mild Cognitive Impairment (CAMCI) to identify cognitive difficulties easily and reliably. In an article in the March issue of Postgraduate Medicine entitled "Computer Assessment of Mild Cognitive Impairment," the program creators detail the procedures and the benefits of the new test, which they claim is sensitive enough to notice the smallest amount of forgetfulness. By conducting a controlled study with 524 people >60 years old, they were able to demonstrate the ease and effectiveness of the testing system.
Medical Devices

Landmark Data Presented At The British Society For Allergy And Clinical Immunology Shows Hay Fever Vaccine Could Be A Reality

New data presented at the British Society for Allergy and Clinical Immunology (BSACI) annual meeting demonstrate that Grazax® is the first tablet treatment to provide sustained disease control in patients with grass pollen rhinoconjunctivitis (hay fever) after the treatment period ended. This is the first time disease modification by sublingual allergy immunotherapy tablets has been achieved; effectively re-setting the immune system to reduce future allergic reactions to grass pollen. The pivotal Grazax GT08 study is an international randomised, parallel-group, double-blind, placebo-controlled multicentre study. Patients were randomised to receive either three years of Grazax or placebo, followed by a two year treatment-free follow up period. Throughout the study all patients had free access to symptomatic medications such as antihistamines and nasal sprays. Sneezing, watery eyes and a blocked nose are amongst the most common symptoms reported by patients with severe hay fever. All of these symptoms improved during the three years of continued treatment. Importantly, one year following discontinuation of treatment, these symptoms remained significantly reduced by 31% (sneezing), 60% (watery eyes) and 51% (blocked nose) compared to the patients who had previously received placebo tablets.1 Furthermore, the need for symptomatic medications was sustained during three years continued treatment and remained significantly reduced in the season one year after stopping treatment, thereby confirming a disease-modifying effect (pReferences 1. Durham S, et al. Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment. XXVIII Congress of the European Academy of Allergy and Clinical Immunology; poster # 333 About Grazax Grazax is a once daily fast-melting tablet which is placed under the tongue (sublingual) and is the first immunotherapy tablet to address the underlying cause of grass pollen allergy. Grazax became available for adults in January 2007 and for children aged 5 to 17 years in February 2009. Grazax is generally well tolerated, with the majority of side effects being transient, local allergic reactions, such as oral pruritus (irritation in the mouth), which was classified as mild to moderate. About the Grazax GT08 study The pivotal Grazax GT08 study is a randomised, parallel-group, double-blind, placebo-controlled multicentre study. Patients were randomised to receive either 3 years of Grazax or placebo, followed by a 2 year follow up period. Throughout the study all patients had free access to symptomatic medications. The data from the 4th year of the GT08 study is based upon a full analysis set that included 283 participants, with a history of grass pollen rhinoconjunctivitis uncontrolled by symptomatic medications The main clinical study end points were: - Rhinoconjunctivitis symptom score - Rhinoconjunctivitis medication score - Quality of Life (QoL) ALK-AbellÃö


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009